CastleKnight Management LP Trims Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

CastleKnight Management LP decreased its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 35.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 425,100 shares of the company's stock after selling 232,221 shares during the period. CastleKnight Management LP owned about 0.49% of Pediatrix Medical Group worth $5,577,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Nomura Asset Management Co. Ltd. raised its holdings in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after acquiring an additional 1,040 shares during the last quarter. AlphaQuest LLC grew its stake in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares during the period. Smartleaf Asset Management LLC increased its holdings in Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in shares of Pediatrix Medical Group by 218.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Down 0.2 %

Shares of Pediatrix Medical Group stock opened at $12.92 on Tuesday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company has a market cap of $1.11 billion, a P/E ratio of -10.77, a PEG ratio of 1.74 and a beta of 1.26. The company's fifty day simple moving average is $13.71 and its two-hundred day simple moving average is $14.00. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. UBS Group upped their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Truist Financial lowered their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.